"New Horizon Research Center is Miami's Premier Clinical Research Facility. New Horizon Research Center es una de las clinicas de investigacion mas reconocida en Miami. Looking for clinical research studies? Give us a call to see if you qualify."

During the past decade, New Horizon Research Center conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 35 clinical trials were completed, i.e. on average, 59.3% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 23 clinical trials were completed. i.e. 69.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Horizon Research Center" #1 sponsor was "Eli Lilly and Company" with 32 trials, followed by "Pfizer" with 8 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 2 trials sponsored and "George Medicines PTY Limited" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Horizon Research Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "New Horizon Research Center" are "Diabetes Mellitus, Type 2" (7 trials), "Type 2 Diabetes" (5 trials), "Type 2 Diabetes Mellitus" (4 trials), "Alzheimer Disease" (3 trials) and "Diabetic Peripheral Neuropathic Pain" (3 trials). Many other conditions were trialed in "New Horizon Research Center" in a lesser frequency.

Most popular intervention types in "New Horizon Research Center" are "Drug" (58 trials), "Biological" (8 trials), "Other" (6 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Tirzepatide" (5 trials), "Dulaglutide" (4 trials), "Baricitinib" (3 trials) and "LY3556050" (3 trials). Other intervention names were less common.

The vast majority of trials in "New Horizon Research Center" are 66 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "New Horizon Research Center". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in New Horizon Research Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in New Horizon Research Center, 0 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".